Joseph Binder

673 total citations
5 papers, 121 citations indexed

About

Joseph Binder is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Joseph Binder has authored 5 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Infectious Diseases and 2 papers in Epidemiology. Recurrent topics in Joseph Binder's work include Virus-based gene therapy research (2 papers), CAR-T cell therapy research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). Joseph Binder is often cited by papers focused on Virus-based gene therapy research (2 papers), CAR-T cell therapy research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). Joseph Binder collaborates with scholars based in United States and Canada. Joseph Binder's co-authors include Annaliesa S. Anderson, Meike Dittmann, Ludovic Desvignes, Ellie Ivanova, Adil Mohamed, Kelly V. Ruggles, Claire M. Steppan, Sergei B. Koralov, Ana M. Valero-Jimenez and Maren de Vries and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and Molecular Cancer Therapeutics.

In The Last Decade

Joseph Binder

5 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Binder United States 4 78 44 37 20 19 5 121
Serap Beldar Canada 5 93 1.2× 31 0.7× 74 2.0× 14 0.7× 13 0.7× 7 192
Vlad Nicolaescu United States 6 72 0.9× 33 0.8× 81 2.2× 9 0.5× 6 0.3× 12 193
Victoria C. Yan United States 8 133 1.7× 29 0.7× 90 2.4× 30 1.5× 30 1.6× 18 272
Almagul Seitova Canada 5 104 1.3× 40 0.9× 59 1.6× 30 1.5× 15 0.8× 8 198
Mohamed Mahdi Hungary 7 124 1.6× 76 1.7× 96 2.6× 10 0.5× 9 0.5× 26 264
Laura Schäkel Germany 7 54 0.7× 64 1.5× 64 1.7× 34 1.7× 12 0.6× 12 201
Alekxander Binderup Denmark 5 148 1.9× 60 1.4× 44 1.2× 5 0.3× 6 0.3× 7 175
Javier Ibáñez Spain 7 31 0.4× 61 1.4× 41 1.1× 22 1.1× 14 0.7× 10 324
Ellie Ivanova United States 6 90 1.2× 44 1.0× 81 2.2× 14 0.7× 9 0.5× 9 183
Paul Radloff Germany 9 55 0.7× 43 1.0× 32 0.9× 17 0.8× 10 0.5× 10 404

Countries citing papers authored by Joseph Binder

Since Specialization
Citations

This map shows the geographic impact of Joseph Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Binder more than expected).

Fields of papers citing papers by Joseph Binder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Binder. The network helps show where Joseph Binder may publish in the future.

Co-authorship network of co-authors of Joseph Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Binder. A scholar is included among the top collaborators of Joseph Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Binder. Joseph Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Powers, Thomas W., Lauren F. Barnes, Benjamin E. Draper, et al.. (2021). Characterization of Recombinant Chimpanzee Adenovirus C68 Low and High-Density Particles: Impact on Determination of Viral Particle Titer. Frontiers in Bioengineering and Biotechnology. 9. 753480–753480. 4 indexed citations
2.
Inoue, Tomoyoshi, Mitsuko Inoue, Patrick Wall, et al.. (2021). Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing. Molecular Cancer Therapeutics. 20(8). 1481–1494. 15 indexed citations
3.
Autio, Karen A., Celestia S. Higano, Luke T. Nordquist, et al.. (2021). First-in-human, phase I study of PF-06753512, a vaccine-based immunotherapy regimen (PrCa VBIR), in biochemical relapse (BCR) and metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 39(15_suppl). 2612–2612. 2 indexed citations
4.
Vries, Maren de, Adil Mohamed, Ana M. Valero-Jimenez, et al.. (2021). A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19. Journal of Virology. 95(10). 93 indexed citations
5.
Binder, Joseph, Karen A. Maegley, Laura Lingardo, et al.. (2011). Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitors. Antiviral Research. 91(2). 102–111. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026